17.01.2023 19:45
A new report from the National Institutes of Health suggests that CBD, including Swissx products, can prevent and inhibit the SARS-CoV-2 infection in human lung cells when they’re used as a therapeutic treatment. Evidence that supports the celebrated doctor’s recommendation to use CBD to fight SARS-CoV-2, the agent responsible for COVID-19, is included in a new study published by The National Center for Biotechnology Information.
